Technology developed at WashU Medicine locates sensitive areas to enhance precision neurosurgery By: Mark Reynolds A new AI-based technology that rapidly maps the brain to locate sensitive areas that control speech, vision, movement and other critical functions has received authorization from the Food and Drug Administration (FDA), enabling it to be marketed to hospitals with […]
AI-based brain-mapping software receives FDA market authorization
